• Eka Funding
  • Book a demo
Esketamine Nasal Spray Approved as Standalone Treatment for Resistant Depression
on
January 25, 2025
Army Hospital Sets New Milestone: First HeartMate 3 LVAD Implantation in a Government InstitutionIn a landmark development for cardiac care, the Army Hospital (Research & Referral) in Delhi Cantonment has performed India’s first-ever Left Ventricular Assist Device (LVAD) implantation with the HeartMate 3 device in a government institution. The successful procedure was conducted on a 49-year-old patient who had been awaiting a heart transplant for over two years.
on
January 24, 2025
3-Day Breakthrough in Myeloid Genomic Testing: Agilus Sets a New BenchmarkAgilus Diagnostics has radically shortened the turnaround time (TAT) for myeloid malignancy genomic testing to just three days—significantly faster than the typical two-to-three-week wait at most labs. This accelerated process empowers physicians to make critical decisions sooner, offering timely interventions and potentially improved outcomes for patients with Acute Myeloid Leukemia (AML) and Myeloproliferative Neoplasms (MPN).
on
January 23, 2025
Pune Reports 22 Suspected Cases of Rare Guillain-Barré SyndromeThe civic health department has identified 22 suspected cases of Guillain-Barré Syndrome (GBS), a rare immunological nerve disorder that causes sudden numbness and muscle weakness. The majority of cases are from the Sinhgad Road area and eight patients currently require ventilator support. Most patients are between 12 and 30 years of age, with one case involving a 59-year-old.
on
January 22, 2025
India Bans Refurbished Medical Device Imports to Boost Safety and InnovationIndia’s medical device industry has welcomed the Central Drugs Standard Control Organisation’s (CDSCO) decision to prohibit the import of refurbished medical devices. The regulatory body clarified that such imports are not permitted under the Medical Devices Rules, 2017, citing the absence of certification protocols to ensure patient safety.
on
January 21, 2025
Previous
Next

Featured

FDA Approves Blujepa (Gepotidacin): First New Oral Antibiotic for uUTIs in Nearly 30 Years
Lorundrostat Shows Promise in Treating Uncontrolled Hypertension in Pivotal Trials
Kerala School Reports Viral Meningitis Cases, Health Authorities on High Alert
DCGI’s Renewed Mandate: Wiping Out Substandard Drugs, Supporting MSMEs, and Regulating Medical Devices
Delhi Sees Surge in H1N1 and Influenza B Cases

Participate in India’s healthcare revolution

Create ABHA & store all your medical records with Eka care (Govt of India ABDM approved PHR app)

Create ABHA ID

Popular topics

#

newfeature

#

Partnership

#

funding

Logo
About
Home
Team
Eka Stories
Google API Disclosure
Products
For Doctors
Eka EMR
EMR for Neurologists
GMB for Doctors
Cowin
Book Vaccination Slot
Download Vaccination Certificate
Change Mobile Number
Add Passport Details
ABDM
Create ABHA
© 2023 eka.care
TermsPrivacySecurity